The timing of sensitisation and its relevance to the prevention of Rh-haemolytic disease.
D000017:ABO Blood-Group System; D001787:Blood Group Incompatibility; D002859:Chromium Isotopes; D036861:Delivery, Obstetric; D004899:Erythroblastosis, Fetal / Q000517:prevention & control*; D005260:Female; D005331:Fetomaternal Transfusion; D006801:Humans; D007114:Immunization; D007231:Infant, Newborn; D008297:Male; D006473:Postpartum Hemorrhage; D011247:Pregnancy; D013997:Time Factors; D005719:gamma-Globulins / Q000008:administration & dosage
D000017:ABO Blood-Group System; D002859:Chromium Isotopes; D005719:gamma-Globulins